Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Authors
Keywords
Advanced glycation end products, Receptor for advanced glycation end products, sRAGE, esRAGE, Atherosclerosis, Type 1 diabetes, CRP
Journal
Cardiovascular Diabetology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-25
DOI
10.1186/s12933-015-0292-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation in childhood type 1 diabetes; influence of glycemic control
- (2015) Martin Heier et al. ATHEROSCLEROSIS
- The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
- (2014) Jing Xue et al. BIOCHEMISTRY
- Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway
- (2013) Qiaojing Qin et al. Cardiovascular Diabetology
- Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)
- (2013) J. K. Y. Lam et al. DIABETIC MEDICINE
- RAGE regulation and signaling in inflammation and beyond
- (2013) Katrin Kierdorf et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Unlocking the biology of RAGE in diabetic microvascular complications
- (2013) Michaele B. Manigrasso et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes
- (2012) Y Yu et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Plasma biomarkers of oxidative and AGE-mediated damage of proteins and glycosaminoglycans during healthy ageing: A possible association with ECM metabolism
- (2012) Katarzyna Komosinska-Vassev et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Induction of RAGE Shedding by Activation of G Protein-Coupled Receptors
- (2012) Verena V. Metz et al. PLoS One
- Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)
- (2011) Barry I. Hudson et al. ATHEROSCLEROSIS
- The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood
- (2011) Cosimo Giannini et al. PEDIATRIC NEPHROLOGY
- Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging
- (2010) Shi Fang Yan et al. BIOCHEMICAL PHARMACOLOGY
- Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes
- (2010) Johanna W.M. Nin et al. DIABETES
- Early Signs of Atherosclerosis in Diabetic Children on Intensive Insulin Treatment: A population-based study
- (2010) H. D. Margeirsdottir et al. DIABETES CARE
- Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women
- (2009) Bente K. Kilhovd et al. ATHEROSCLEROSIS
- Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms
- (2009) N. Grossin et al. DIABETES & METABOLISM
- Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study
- (2009) J. W. M. Nin et al. DIABETOLOGIA
- The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging
- (2009) Eriko Y. Fujii et al. FERTILITY AND STERILITY
- Regulation of alternative splicing of the receptor for advanced glycation endproducts (RAGE) through G-rich cis-elements and heterogenous nuclear ribonucleoprotein H
- (2009) Kazuyo Ohe et al. JOURNAL OF BIOCHEMISTRY
- Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes
- (2008) Naoto Katakami et al. ATHEROSCLEROSIS
- Calcium-regulated intramembrane proteolysis of the RAGE receptor
- (2008) Arnaud Galichet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Role of AGEs in Cardiovascular Disease
- (2008) Karin Jandeleit-Dahm et al. CURRENT PHARMACEUTICAL DESIGN
- Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients
- (2008) Naoto Katakami et al. Diabetes & Vascular Disease Research
- A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
- (2008) Angela Raucci et al. FASEB JOURNAL
- Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
- (2008) Ling Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification, classification, and expression of RAGE gene splice variants
- (2007) Barry I. Hudson et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started